Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.
about
Vaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalSelected Aspects in the Pathogenesis of Autoimmune DiseasesComparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus.Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II.Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies.Mortality in Systemic Lupus Erythematosus: an Updated Review.Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States.Complement levels and risk of organ involvement in patients with systemic lupus erythematosus.Sex, Symptom Severity, and Quality of Life in Rheumatology.Late-onset systemic lupus erythematosus: Is it "mild lupus"?Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?Improvement of survival rates in the last decade in Thai childhood-onset systemic lupus erythematosus
P2860
Q26749096-579F8B4C-1A04-48CC-B5F2-E0A466BDB22EQ26795580-D8E050C9-08E0-4A3F-A1D3-90A91852D45AQ33423725-F4ACC9AB-615E-42F8-8F9D-B5DDAF267C42Q33436712-209E6457-2441-4EAF-8B87-8B9E73A4F76FQ36540710-75C63369-E127-4192-A5A5-1D10AFA64C48Q38255986-92CC85A3-3D08-4DA5-AFB1-807E8A5B00F8Q38400086-9A246FEC-2B7A-49F6-9E69-ACDCF08ED2ACQ38777770-A067C6BD-AA26-4FB0-BC6B-E729F49043F4Q40042816-5CA65D43-1B56-40B8-B140-B30968F09C94Q40156825-64402057-9585-4BE0-8C4B-C033129F086AQ46140324-163B1624-F373-4A8A-9B45-065A1E868EE0Q47096234-D67A3715-C6C7-4DDB-9849-6CD819251636Q47671088-28D1D474-BA42-4874-A483-8573755297FAQ48628328-51690EE5-63E2-4B2E-BF6E-454095D7EC6DQ49942692-8E8E9CFE-EB05-48EE-A9AC-E2B767530D57Q51069196-5B317521-9306-40A9-82E2-26D96653373CQ58795695-14C1E97A-D9C2-4799-9E5D-30EE73974CE8
P2860
Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical manifestations and su ...... according to age at diagnosis.
@ast
Clinical manifestations and su ...... according to age at diagnosis.
@en
Clinical manifestations and survival among adults with
@nl
type
label
Clinical manifestations and su ...... according to age at diagnosis.
@ast
Clinical manifestations and su ...... according to age at diagnosis.
@en
Clinical manifestations and survival among adults with
@nl
prefLabel
Clinical manifestations and su ...... according to age at diagnosis.
@ast
Clinical manifestations and su ...... according to age at diagnosis.
@en
Clinical manifestations and survival among adults with
@nl
P2093
P2860
P356
P1433
P1476
Clinical manifestations and su ...... according to age at diagnosis.
@en
P2093
E Massarotti
E W Karlson
J F Merola
K H Costenbader
P2860
P304
P356
10.1177/0961203314526291
P577
2014-03-07T00:00:00Z